Search
Login
My Portfolios Login
TradeMachine® Login
CML Research Pro Login
PatternFinder Login
Sign Up
Get TradeMachine®
Get CML Research
Get PatternFinder
Get TradeMachine®
Get CML Research
Get PatternFinder
Compare Products
Home
My Portfolios
CMLViz News
Breaking
Stock
Scanner
Tear Sheet
News
Profile
Stats
Stock Chart
Pivot Points
Financial Charts
Holders
Analysts
Day Trader
Back-Tester
SPX
4,109.31
+57.94
(
+1.41%
)
Dow 30
+1.26%
QQQ
+1.66%
VIX
18.7
-0.32
(
-1.68%
)
Carisma Therapeutics Inc
:SESN 4:00:00 PM EDT
3.10
+0.01
(
+0.32%
)
5:08:56 PM EDT: $3.10
0.00 (0.00%)
Products
Sesen Bio Submits Completed Biologics License Application To The FDA For Vicineum™ And Has Requested Priority Review
Published: 12/21/2020 16:31 GMT
SESN
(
SESN
)
- Sesen Bio Submits Completed Biologics License Application to the FDA for Vicineum™ and Has Requested Priority Review.
